141 related articles for article (PubMed ID: 22844776)
1. [Molecular mechanisms of axon degeneration regulated by the ubiquitin proteasome system].
Wakatsuki S; Araki T
Seikagaku; 2012 Jun; 84(6):463-71. PubMed ID: 22844776
[No Abstract] [Full Text] [Related]
2. ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation.
Wakatsuki S; Saitoh F; Araki T
Nat Cell Biol; 2011 Nov; 13(12):1415-23. PubMed ID: 22057101
[TBL] [Abstract][Full Text] [Related]
3. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
Hatakeyama S
Seikagaku; 2005 May; 77(5):389-99. PubMed ID: 15952328
[No Abstract] [Full Text] [Related]
4. [Involvement of ubiquitin-proteasome system in polyglutamine disease].
Matsumoto M
Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1428-32. PubMed ID: 16922413
[No Abstract] [Full Text] [Related]
5. Age-related dysfunctions of the autophagy lysosomal pathway in hippocampal pyramidal neurons under proteasome stress.
Gavilán E; Pintado C; Gavilan MP; Daza P; Sánchez-Aguayo I; Castaño A; Ruano D
Neurobiol Aging; 2015 May; 36(5):1953-63. PubMed ID: 25817083
[TBL] [Abstract][Full Text] [Related]
6. Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity.
Fang W; Gao G; Zhao H; Xia Y; Guo X; Li N; Li Y; Yang Y; Chen L; Wang Q; Li L
Brain Res; 2015 Mar; 1602():9-19. PubMed ID: 25150591
[TBL] [Abstract][Full Text] [Related]
7. [Integrated molecular medicine for neuronal and neoplastic disorders].
Tanaka F; Sobue G
Seikagaku; 2007 Feb; 79(2):121-30. PubMed ID: 17370616
[No Abstract] [Full Text] [Related]
8. [TGF-beta signaling].
Imamura T; Koinuma D
Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1277-81. PubMed ID: 16922387
[No Abstract] [Full Text] [Related]
9. Cell biology. GSK-3beta and microtubule assembly in axons.
Zhou FQ; Snider WD
Science; 2005 Apr; 308(5719):211-4. PubMed ID: 15825222
[No Abstract] [Full Text] [Related]
10. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system.
Watts RJ; Hoopfer ED; Luo L
Neuron; 2003 Jun; 38(6):871-85. PubMed ID: 12818174
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanism of axon guidance mediated by phosphorylation of CRMP2].
Uchida Y; Goshima Y
Seikagaku; 2005 Nov; 77(11):1424-7. PubMed ID: 16370363
[No Abstract] [Full Text] [Related]
12. [Neuronal polarity].
Arimura N; Yoshimura T; Kaibuchi K
Tanpakushitsu Kakusan Koso; 2006 May; 51(6 Suppl):789-95. PubMed ID: 16719345
[No Abstract] [Full Text] [Related]
13. [Molecular mechanisms regulating neuronal polarity via phosphorylation signaling].
Yoshimura T; Arimura N; Hattori A; Kaibuchi K
Tanpakushitsu Kakusan Koso; 2007 Jun; 52(7):753-9. PubMed ID: 17552280
[No Abstract] [Full Text] [Related]
14. Changes in microtubule-related proteins and autophagy in long-term vitamin E-deficient mice.
Fukui K; Masuda A; Hosono A; Suwabe R; Yamashita K; Shinkai T; Urano S
Free Radic Res; 2014 Jun; 48(6):649-58. PubMed ID: 24568262
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin, proteasome and parkin.
Tanaka K; Suzuki T; Hattori N; Mizuno Y
Biochim Biophys Acta; 2004 Nov; 1695(1-3):235-47. PubMed ID: 15571819
[TBL] [Abstract][Full Text] [Related]
16. [The ubiquitin-proteosome system: The deadly kiss].
Kotsias BA
Medicina (B Aires); 2010; 70(2):194-6. PubMed ID: 20447906
[No Abstract] [Full Text] [Related]
17. Augmentation of the ubiquitin-mediated proteolytic system by F-box and additional motif-containing proteins (Review).
Sato K; Yoshida K
Int J Oncol; 2010 Nov; 37(5):1071-6. PubMed ID: 20878054
[TBL] [Abstract][Full Text] [Related]
18. NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC.
Zhou FQ; Zhou J; Dedhar S; Wu YH; Snider WD
Neuron; 2004 Jun; 42(6):897-912. PubMed ID: 15207235
[TBL] [Abstract][Full Text] [Related]
19. Cooperation of molecular chaperones with the ubiquitin/proteasome system.
Esser C; Alberti S; Höhfeld J
Biochim Biophys Acta; 2004 Nov; 1695(1-3):171-88. PubMed ID: 15571814
[TBL] [Abstract][Full Text] [Related]
20. Axon pathology in neurological disease: a neglected therapeutic target.
Coleman MP; Perry VH
Trends Neurosci; 2002 Oct; 25(10):532-7. PubMed ID: 12220882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
